
Dren Bio announces a $60M Series A financing
SAN CARLOS, Calif.–(BUSINESS WIRE)–Dren Bio, Inc., a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents, announced the closing […]

